Aspargo Laboratories

About:

Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.

Website: https://aspargolabs.com/

Twitter/X: AspargoLabs

Description:

Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients with dysphagia (trouble swallowing). The company develops patient-focused solutions and medicines by combining their innovative science and technology. Its initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRACurrently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia, and China. Applications for approval are planned for Croatia, France, Germany, and Austria.

Total Funding Amount:

$67.9M

Headquarters Location:

Englewood, New Jersey, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)aspargolabs.com

Founders:

Michael Demurjian

Number of Employees:

1-10

Last Funding Date:

2022-03-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai